vs
Side-by-side financial comparison of ASTRAZENECA PLC (AZN) and HP Inc. (HPQ). Click either name above to swap in a different company.
HP Inc. is the larger business by last-quarter revenue ($14.6B vs $14.5B, roughly 1.0× ASTRAZENECA PLC). ASTRAZENECA PLC runs the higher net margin — 16.9% vs 5.4%, a 11.5% gap on every dollar of revenue. On growth, ASTRAZENECA PLC posted the faster year-over-year revenue change (11.7% vs 4.2%).
AstraZeneca plc (AZ) is a Swedish-British multinational pharmaceutical and biotechnology company with its headquarters at the Cambridge Biomedical Campus in Cambridge, UK. It has a portfolio of products for major diseases in areas including oncology, cardiovascular, gastrointestinal, infection, neuroscience, respiratory, and inflammation.
The Hewlett-Packard Company, commonly shortened to Hewlett-Packard or HP, was an American multinational information technology company. It was founded by Bill Hewlett and David Packard in 1939 in a one-car garage in Palo Alto, California. Growing to become an influential high-tech powerhouse at the heart of Silicon Valley, the company was known for its progressive business philosophy, deemed the HP Way.
AZN vs HPQ — Head-to-Head
Income Statement — Q2 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $14.5B | $14.6B |
| Net Profit | $2.4B | $795.0M |
| Gross Margin | 82.9% | 20.2% |
| Operating Margin | 24.3% | 6.6% |
| Net Margin | 16.9% | 5.4% |
| Revenue YoY | 11.7% | 4.2% |
| Net Profit YoY | 27.0% | -12.3% |
| EPS (diluted) | $1.57 | $0.84 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | — | $14.6B | ||
| Q3 25 | — | $13.9B | ||
| Q2 25 | $14.5B | $13.2B | ||
| Q1 25 | — | $13.5B | ||
| Q4 24 | — | $14.1B | ||
| Q3 24 | — | $13.5B | ||
| Q2 24 | $12.9B | $12.8B | ||
| Q1 24 | — | $13.2B |
| Q4 25 | — | $795.0M | ||
| Q3 25 | — | $763.0M | ||
| Q2 25 | $2.4B | $406.0M | ||
| Q1 25 | — | $565.0M | ||
| Q4 24 | — | $906.0M | ||
| Q3 24 | — | $640.0M | ||
| Q2 24 | $1.9B | $607.0M | ||
| Q1 24 | — | $622.0M |
| Q4 25 | — | 20.2% | ||
| Q3 25 | — | 20.5% | ||
| Q2 25 | 82.9% | 20.7% | ||
| Q1 25 | — | 21.0% | ||
| Q4 24 | — | 21.4% | ||
| Q3 24 | — | 21.5% | ||
| Q2 24 | 83.1% | 23.6% | ||
| Q1 24 | — | 21.9% |
| Q4 25 | — | 6.6% | ||
| Q3 25 | — | 5.1% | ||
| Q2 25 | 24.3% | 4.9% | ||
| Q1 25 | — | 6.3% | ||
| Q4 24 | — | 7.1% | ||
| Q3 24 | — | 7.0% | ||
| Q2 24 | 21.2% | 7.4% | ||
| Q1 24 | — | 7.1% |
| Q4 25 | — | 5.4% | ||
| Q3 25 | — | 5.5% | ||
| Q2 25 | 16.9% | 3.1% | ||
| Q1 25 | — | 4.2% | ||
| Q4 24 | — | 6.4% | ||
| Q3 24 | — | 4.7% | ||
| Q2 24 | 14.9% | 4.7% | ||
| Q1 24 | — | 4.7% |
| Q4 25 | — | $0.84 | ||
| Q3 25 | — | $0.80 | ||
| Q2 25 | $1.57 | $0.42 | ||
| Q1 25 | — | $0.59 | ||
| Q4 24 | — | $0.93 | ||
| Q3 24 | — | $0.65 | ||
| Q2 24 | $1.24 | $0.61 | ||
| Q1 24 | — | $0.62 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $7.1B | $3.7B |
| Total DebtLower is stronger | — | $9.7B |
| Stockholders' EquityBook value | $44.8B | $-346.0M |
| Total Assets | $112.4B | $41.8B |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $3.7B | ||
| Q3 25 | — | $2.9B | ||
| Q2 25 | $7.1B | $2.7B | ||
| Q1 25 | — | $2.9B | ||
| Q4 24 | — | $3.2B | ||
| Q3 24 | — | $2.8B | ||
| Q2 24 | $6.9B | $2.4B | ||
| Q1 24 | — | $2.3B |
| Q4 25 | — | $9.7B | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | $9.7B | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
| Q4 25 | — | $-346.0M | ||
| Q3 25 | — | $-901.0M | ||
| Q2 25 | $44.8B | $-1.3B | ||
| Q1 25 | — | $-1.1B | ||
| Q4 24 | — | $-1.3B | ||
| Q3 24 | — | $-1.4B | ||
| Q2 24 | $39.6B | $-916.0M | ||
| Q1 24 | — | $-1.6B |
| Q4 25 | — | $41.8B | ||
| Q3 25 | — | $39.9B | ||
| Q2 25 | $112.4B | $38.8B | ||
| Q1 25 | — | $38.9B | ||
| Q4 24 | — | $39.9B | ||
| Q3 24 | — | $38.1B | ||
| Q2 24 | $104.3B | $37.4B | ||
| Q1 24 | — | $35.8B |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | — | $1.6B |
| Free Cash FlowOCF − Capex | — | $1.4B |
| FCF MarginFCF / Revenue | — | 9.7% |
| Capex IntensityCapex / Revenue | — | 1.3% |
| Cash ConversionOCF / Net Profit | — | 2.04× |
| TTM Free Cash FlowTrailing 4 quarters | — | $2.8B |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $1.6B | ||
| Q3 25 | — | $1.7B | ||
| Q2 25 | — | $38.0M | ||
| Q1 25 | — | $374.0M | ||
| Q4 24 | — | $1.6B | ||
| Q3 24 | — | $1.4B | ||
| Q2 24 | — | $581.0M | ||
| Q1 24 | — | $121.0M |
| Q4 25 | — | $1.4B | ||
| Q3 25 | — | $1.4B | ||
| Q2 25 | — | $-145.0M | ||
| Q1 25 | — | $72.0M | ||
| Q4 24 | — | $1.5B | ||
| Q3 24 | — | $1.3B | ||
| Q2 24 | — | $462.0M | ||
| Q1 24 | — | $-37.0M |
| Q4 25 | — | 9.7% | ||
| Q3 25 | — | 10.4% | ||
| Q2 25 | — | -1.1% | ||
| Q1 25 | — | 0.5% | ||
| Q4 24 | — | 10.5% | ||
| Q3 24 | — | 9.3% | ||
| Q2 24 | — | 3.6% | ||
| Q1 24 | — | -0.3% |
| Q4 25 | — | 1.3% | ||
| Q3 25 | — | 1.5% | ||
| Q2 25 | — | 1.4% | ||
| Q1 25 | — | 2.2% | ||
| Q4 24 | — | 1.1% | ||
| Q3 24 | — | 1.2% | ||
| Q2 24 | — | 0.9% | ||
| Q1 24 | — | 1.2% |
| Q4 25 | — | 2.04× | ||
| Q3 25 | — | 2.18× | ||
| Q2 25 | — | 0.09× | ||
| Q1 25 | — | 0.66× | ||
| Q4 24 | — | 1.79× | ||
| Q3 24 | — | 2.23× | ||
| Q2 24 | — | 0.96× | ||
| Q1 24 | — | 0.19× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
AZN
Segment breakdown not available.
HPQ
| Commercial PS | $7.0B | 48% |
| Consumer PS | $3.4B | 23% |
| Supplies | $2.8B | 19% |
| Commercial Printing | $1.2B | 8% |
| Consumer Printing | $296.0M | 2% |
| Corporate Investments | $19.0M | 0% |
